doi: 10.1371/journal.pone.0198347
Epithalon and Geroprotective Outcomes A large, long-term study followed 266 elderly subjects (60+ years) over a 68 year period.(13,14) Participants were divided into groups receiving: Thymalin Epithalon A combination of Thymalin + Epithalon Control conditions Reported outcomes: Improved function of cardiovascular, endocrine, immune, and nervous systems Normalization of metabolic and hemostatic parameters Approximately 2 reduction in the incidence of common age-related diseases (e.g., acute respiratory illnesses, heart disease, and bone pathology) Decreased mortality: ~ 2-fold reduction with Thymalin ~ 1.8-fold reduction with Epithalon ~ 2.5-fold reduction with the combination These data suggest that Epithalon, alone or in combination with other peptide bioregulators, may exhibit geroprotective potential in elderly cohorts under specific experimental conditions

Several studies have shown that oleuropein decreases cancer cell viability and exhibits pro-apoptotic effects through the p53-dependent pathway and by activating BAX and Bcl-2 genes in breast cancer cells (MCF-7) [123]
McKenna: glutamate as energy substrate and neurotransmitterfunctional interaction between neurons and astrocytes
from Howard University School of Law